MeiraGTx Holdings (FRA:328) Short Interest


FRA:328 MeiraGTx Holdings PLC FRA:328
51 GF Score
Price €10.30
GF Value €21.06
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MeiraGTx Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:328 vs DRTS, LXRX, CGEM: Short Interest Comparison

For the Biotechnology subindustry, MeiraGTx Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeiraGTx Holdings Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MeiraGTx Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where MeiraGTx Holdings's Short Interest falls into.


FRA:328
51GF Score
MeiraGTx Holdings PLC FRA:328
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MeiraGTx Holdings (FRA:328) Overvalued in 2026?

Based on GuruFocus' analysis, MeiraGTx Holdings stock appears to be undervalued. The current stock price of €10.30 is trading 51.1% below its estimated GF Value™ of €21.06. GuruFocus considers MeiraGTx Holdings to be Possible Value Trap.

Key valuation signals for FRA:328:

  • Short Interest:
  • GF Value™: €21.06 vs. price of €10.30 (51.1% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the FRA:328 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MeiraGTx Holdings Business Description

Other Exchanges MGTX:USA328:Germany
Address 655 Third Avenue, Suite 1115, New York, NY, USA, 10017
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
51GF Score

Get the complete analysis for FRA:328

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.30
Price
€21.06
GF Value